This open-access journal is dedicated to advancing the understanding and treatment of hematologic malignancies and related disorders. The primary focus is on publishing high-quality research that spans from basic science discoveries to translational and clinical studies. The goal is to improve the lives of patients with cancer.
Key topics covered in the journal include molecular mechanisms of cancer, innovative therapeutic approaches, clinical trials, drug development, and biomarkers. It also focuses on the development of targeted therapies, immunotherapy, and personalized medicine approaches.
The journal aims to promote interdisciplinary collaboration and provides a platform for researchers and clinicians to share their expertise and findings. It is indexed in major databases, including PubMed, Scopus, and Web of Science. It encourages submissions of original research, reviews, and meta-analyses, fostering rapid dissemination of cutting-edge advancements in the field of hematology and oncology. It is essential reading for researchers, oncologists, hematologists, and other healthcare professionals focused on advancing cancer care.